Literature DB >> 5649002

Body height and imipramine side-effects.

A M Porter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5649002      PMCID: PMC1985963          DOI: 10.1136/bmj.2.5602.406

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  6 in total

1.  EFFECT OF DRUGS ON THE FORMATION OF SMOOTH ENDOPLASMIC RETICULUM AND DRUG-METABOLIZING ENZYMES.

Authors:  H REMMER; H J MERKER
Journal:  Ann N Y Acad Sci       Date:  1965-03-12       Impact factor: 5.691

2.  INDIVIDUAL VARIATIONS OF DRUG METABOLISM AS A FACTOR IN DRUG TOXICITY.

Authors:  D A EVANS
Journal:  Ann N Y Acad Sci       Date:  1965-03-12       Impact factor: 5.691

3.  THE INFLUENCE OF ACETYLATOR PHENOTYPE ON THE EFFECTS OF TREATING DEPRESSION WITH PHENELZINE.

Authors:  D A EVANS; K DAVISON; R T PRATT
Journal:  Clin Pharmacol Ther       Date:  1965 Jul-Aug       Impact factor: 6.875

4.  Drug reactions enzymes, and biochemical genetics.

Authors:  A G MOTULSKY
Journal:  J Am Med Assoc       Date:  1957-10-19

5.  Plasma levels of imipramine and desmethylimipramine during therapy.

Authors:  J P Moody; A C Tait; A Todrick
Journal:  Br J Psychiatry       Date:  1967-02       Impact factor: 9.319

6.  Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds.

Authors:  W Hammer; F Sjöqvist
Journal:  Life Sci       Date:  1967-09-01       Impact factor: 5.037

  6 in total
  1 in total

1.  Depressive illness in a general practice. A demographic study and a controlled trial of imipramine.

Authors:  A M Porter
Journal:  Br Med J       Date:  1970-03-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.